Drug details:
Molecular formula: C₁₀H₁₂NO₅P

Standard name: [2-(4-acetylanilino)-2-oxoethyl]phosphonic acid

Curated SMILES: CC(=O)C1=CC=C(NC(=O)CP(=O)([O-])[O-])C=C1

Evidence for compound's anti-virulence activity:

Bacillus
Related VF: Collagenase
Target: ColQ1
Drug effect: Binds to bacterial collagenase to inhibit their activity thus to reduce cytotoxicity to host cells.
Max phase: Preclinical (in vivo)
Publication:
Alhayek A, et al., 2022. Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin-Wound Infections. Adv Ther (Weinh) 5(3):2100222.